Division of Targeted Research
Fax +41(0)31 305 29 70 E-Mail [email protected] NRP Endocrine Disruptors Intermediate Summary Biological activity of complex mixtures of endocrine disruptors Project leader
Prof. Dr. Hanspeter Naegeli Project number
4050-66572 English Summary Biological activty of complex estrogenic mixtures There is general concern that the permanent low-dose exposure to various man-made chemicals with estrogenic activity may be linked to adverse health effect such as breast cancer, male sterility or other reproductive dysfunctions. Project description: Research questions Endogenous estrogens play a fundamental role in human and animal reproduction, as well
as in normal development and tissue differentiation. Normal estrogen signaling pathways culminate in the up- or down-regulation of specific genes in target cells. However, a large number of man-made chemicals and naturally occurring phytoestrogens are able to disrupt
these physiologic responses. Here, the molecular mode of action of such estrogenic chemicals was recorded by monitoring global alterations of gene function in two human
breast cell lines. Results
Cultured human breast cells were exposed to the endogenously produced estrogenic hormone 17β-estradiol, and to typical representatives of natural or man-made xenoestrogens, i.e., estrogenic substances that are foreign to the body. These test
compounds include the phytoestrogen genistein and the industrial chemicals bisphenol-A and PCB-54. Subsequently, a comprehensive analysis of early genome functions was performed using large-scale oligonucleotide microarrays (“DNA chips”) that display the
sequences of essentially all known human genes. Surprisingly, these DNA chip experiments showed that all three xenoestrogens induce identical genomic fingerprints by
reprogramming exactly the same selection of human genes. Also, the stereotyped genomic signature induced by xenoestrogens was undistinguishable from the effects of the endogenous 17β-estradiol. For example, all xenoestrogens suppressed genes involved in cell-
to-cell adhesion while inhibiting cell death and promoting cell growth, DNA replication, and cell division.
Significance: Our large-scale molecular analysis revealed identical actions of diverse estrogenic chemicals, down to the level of single human genes. This unexpected functional convergence reinforces the hypothesis that multiple xenoestrogens may act together to
produce hazardous effects when combined at low doses. The potential response to mixtures of redundant xenostrogens is likely to be underestimated when risk assessments are based on the separate characterization of single components. Hence, we conclude that new
regulatory measures should be introduced to account for the possible impact of multiple low-dose exposures to dietary and environmental estrogens. Perspectives We are now planning to assess the overall biological activity of xenoestrogens in relevant
biological samples such as human breast milk.
Managing inadequate response to treatmentFailure of response to initial therapy or loss of initial BP control occurs due to a wide range of prescriber-related, patient-related and drug-related factors. First, check that treatment has followed recommended prescribing guidelines for achieving BP targets (see Drug treatment , page 19). If BP remains above target despite maximal doses of at least tw